Literature DB >> 9159396

Distribution of pre-mRNA splicing factors at sites of RNA polymerase II transcription.

K M Neugebauer1, M B Roth.   

Abstract

If pre-mRNA splicing begins during RNA synthesis, then transcriptionally active genes may be expected to contain high concentrations of pre-mRNA splicing factors. However, previous studies have localized splicing factors to a network of "speckles," which is distinct from individual sites of gene transcription where pre-mRNA is spliced. Speckles have been detected with antibodies specific for splicing snRNPs and members of the SR family of splicing factors. Here we report that dilution of these probes results in the visualization of hundreds of sites throughout the HeLa cell nucleus, the size and distribution of which are consistent with transcription units viewed with light microscopy. Importantly, these sites of highest SR protein concentration frequently coincide in three-dimensional space with active sites of RNA polymerase II transcription. A newly developed reagent specific for a single member of the SR family, SRp20, detects a subset (approximately 20%) of these sites, suggesting the gene-specific accumulation of these splicing regulators, which have distinct functions in pre-mRNA splicing. These observations question the view that the nucleus and its functions are highly compartmentalized; instead, they support a model in which the localization of these and possibly other gene regulators is determined primarily by their function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9159396     DOI: 10.1101/gad.11.9.1148

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  55 in total

1.  Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.

Authors:  D C Barnard; J G Patton
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 2.  Spatial organization of RNA polymerase II transcription in the nucleus.

Authors:  M N Szentirmay; M Sawadogo
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

3.  Pre-mRNA splicing alters mRNP composition: evidence for stable association of proteins at exon-exon junctions.

Authors:  H Le Hir; M J Moore; L E Maquat
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

4.  Nuclear pre-mRNA compartmentalization: trafficking of released transcripts to splicing factor reservoirs.

Authors:  I Melcák; S Cermanová; K Jirsová; K Koberna; J Malínský; I Raska
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

5.  A cis-acting element in the 3'-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR.

Authors:  F Osman; N Jarrous; Y Ben-Asouli; R Kaempfer
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

6.  Prespliceosomal assembly on microinjected precursor mRNA takes place in nuclear speckles.

Authors:  I Melcák; S Melcáková; V Kopský; J Vecerová; I Raska
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

7.  In situ transcription and splicing in the Balbiani ring 3 gene.

Authors:  I Wetterberg; J Zhao; S Masich; L Wieslander; U Skoglund
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

8.  Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation.

Authors:  Martin Dufva; Josefine Flodin; Annika Nerstedt; Ulla Rüetschi; Lars Rymo
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

9.  Inefficient processing impairs release of RNA from the site of transcription.

Authors:  N Custódio; M Carmo-Fonseca; F Geraghty; H S Pereira; F Grosveld; M Antoniou
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

10.  Viral proteinase requirements for the nucleocytoplasmic relocalization of cellular splicing factor SRp20 during picornavirus infections.

Authors:  Kerry D Fitzgerald; Amanda J Chase; Andrea L Cathcart; Genevieve P Tran; Bert L Semler
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.